A Case of Disseminated Tuberculosis in a Child with Crohn's Disease After Treatment with Azathioprine, Adalimumab and Ustekinumab

Arch Bronconeumol. 2021 Aug;57(8):552-554. doi: 10.1016/j.arbr.2020.11.018.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab / adverse effects
  • Azathioprine / adverse effects
  • Child
  • Crohn Disease* / complications
  • Crohn Disease* / drug therapy
  • Granuloma
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Treatment Outcome
  • Tuberculosis, Miliary* / drug therapy
  • Tuberculosis, Miliary* / etiology
  • Ustekinumab / adverse effects

Substances

  • Immunosuppressive Agents
  • Ustekinumab
  • Adalimumab
  • Azathioprine